Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
23 Oct 2020
Historique:
received: 16 01 2020
accepted: 14 10 2020
entrez: 24 10 2020
pubmed: 25 10 2020
medline: 20 1 2021
Statut: epublish

Résumé

Tailored and culturally appropriate latent tuberculosis (TB) infection screening and treatment programs, including interventions against TB stigma, are needed to reduce TB incidence in low TB incidence countries. However, we lack insights in stigma related to latent TB infection (LTBI) among target groups, such as asylum seekers and refugees. We therefore studied knowledge, attitudes, beliefs, and stigma associated with LTBI among Eritrean asylum seekers and refugees in the Netherlands. We used convenience sampling to interview adult Eritrean asylum seekers and refugees: 26 semi-structured group interviews following TB and LTBI related health education and LTBI screening, and 31 semi-structured individual interviews with Eritreans during or after completion of LTBI treatment (November 2016-May 2018). We used a thematic analysis to identify, analyse and report patterns in the data. Despite TB/LTBI education, misconceptions embedded in cultural beliefs about TB transmission and prevention persisted. Fear of getting infected with TB was the cause of reported enacted (isolation and gossip) and anticipated (concealment of treatment and self-isolation) stigma by participants on LTBI treatment. The inability to differentiate LTBI from TB disease and consequent fear of getting infected by persons with LTBI led to enacted and anticipated stigma comparable to stigma related to TB disease among Eritreans. Additional to continuous culturally sensitive education activities, TB prevention programs should implement evidence-based interventions reducing stigma at all phases in the LTBI screening and treatment cascade.

Sections du résumé

BACKGROUND BACKGROUND
Tailored and culturally appropriate latent tuberculosis (TB) infection screening and treatment programs, including interventions against TB stigma, are needed to reduce TB incidence in low TB incidence countries. However, we lack insights in stigma related to latent TB infection (LTBI) among target groups, such as asylum seekers and refugees. We therefore studied knowledge, attitudes, beliefs, and stigma associated with LTBI among Eritrean asylum seekers and refugees in the Netherlands.
METHODS METHODS
We used convenience sampling to interview adult Eritrean asylum seekers and refugees: 26 semi-structured group interviews following TB and LTBI related health education and LTBI screening, and 31 semi-structured individual interviews with Eritreans during or after completion of LTBI treatment (November 2016-May 2018). We used a thematic analysis to identify, analyse and report patterns in the data.
RESULTS RESULTS
Despite TB/LTBI education, misconceptions embedded in cultural beliefs about TB transmission and prevention persisted. Fear of getting infected with TB was the cause of reported enacted (isolation and gossip) and anticipated (concealment of treatment and self-isolation) stigma by participants on LTBI treatment.
CONCLUSION CONCLUSIONS
The inability to differentiate LTBI from TB disease and consequent fear of getting infected by persons with LTBI led to enacted and anticipated stigma comparable to stigma related to TB disease among Eritreans. Additional to continuous culturally sensitive education activities, TB prevention programs should implement evidence-based interventions reducing stigma at all phases in the LTBI screening and treatment cascade.

Identifiants

pubmed: 33097021
doi: 10.1186/s12889-020-09697-z
pii: 10.1186/s12889-020-09697-z
pmc: PMC7585221
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1602

Subventions

Organisme : ZonMw
ID : 50-53000-98-128

Références

Emerg Infect Dis. 2020 Apr;26(4):675-681
pubmed: 32186488
Int J Infect Dis. 2017 Mar;56:85-89
pubmed: 27836793
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637
pubmed: 28482956
Int J Infect Dis. 2017 Mar;56:90-100
pubmed: 27810521
Psychol Health Med. 2006 Aug;11(3):353-63
pubmed: 17130071
BMC Public Health. 2020 Mar 12;20(1):315
pubmed: 32164637
Eur Respir J. 2019 Nov 28;54(5):
pubmed: 31537698
Int J Family Med. 2015;2015:546042
pubmed: 26690263
Am J Trop Med Hyg. 2018 Nov;99(5):1114-1116
pubmed: 30226149
Lancet Infect Dis. 2017 May;17(5):e128-e143
pubmed: 28291721
J Immigr Minor Health. 2012 Feb;14(1):14-22
pubmed: 20853177
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):840-851
pubmed: 28786791
Sociol Health Illn. 2009 Apr;31(3):441-55
pubmed: 19366430
Psychol Health Med. 2006 Aug;11(3):307-34
pubmed: 17130068
Int J Tuberc Lung Dis. 2014 Feb;18(2):168-73, i-iv
pubmed: 24429308
J Racial Ethn Health Disparities. 2017 Feb;4(1):47-58
pubmed: 26715219
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86
pubmed: 29025489
PLoS One. 2016 Feb 01;11(2):e0147274
pubmed: 26829713
J Health Popul Nutr. 2018 Jan 5;37(1):1
pubmed: 29304840
PLoS One. 2013 Dec 05;8(12):e82440
pubmed: 24349284
PLoS One. 2019 Jul 1;14(7):e0219252
pubmed: 31260502
Am J Trop Med Hyg. 2015 Mar;92(3):625-32
pubmed: 25510722
J Adv Nurs. 2018 Dec;74(12):2755-2765
pubmed: 29964334
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
Public Health. 2018 May;158:55-60
pubmed: 29567507
PLoS One. 2016 Apr 07;11(4):e0152900
pubmed: 27054714
Public Health Rep. 2010 Jul-Aug;125 Suppl 4:34-42
pubmed: 20626191

Auteurs

Ineke Spruijt (I)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands. ineke.spruijt@kncvtbc.org.
Department of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. ineke.spruijt@kncvtbc.org.

Dawit Tesfay Haile (DT)

Department of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Susan van den Hof (S)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.
Present Address: National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands.

Kathy Fiekert (K)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.

Niesje Jansen (N)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.

Degu Jerene (D)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.

Eveline Klinkenberg (E)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.
Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

Ieva Leimane (I)

KNCV Tuberculosis Foundation, Maanweg 174, 2516, AB, The Hague, The Netherlands.

Jeanine Suurmond (J)

Department of Public Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH